Tularemia

• CLINICAL_TRIALS research · 2025-03-05
  Clinical Trial Update: Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Diseases [NA]

  A Montpellier-based clinical trial is assessing serological exposure of professionals to multiple zoonotic pathogens, with status NOT_YET_RE…

• CLINICAL_TRIALS trial_result · 2024-12-13
  Clinical Trial Update: Seroprevalence of Leptospirosis in Val Müstair, Switzerland

  A completed clinical trial update from University Hospital Basel reports seroprevalence data for Leptospirosis, Hepatitis E, and Tularemia i…

• CLINICAL_TRIALS trial_result · 2021-04-29
  Clinical Trial Update: Continued Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine [Phase 2]

  Phase 2 safety and immunogenicity study update for a live Francisella tularensis vaccine targeting tularemia.

• CLINICAL_TRIALS trial_result · 2017-07-02
  Clinical Trial Update: Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine [Phase 2]

  Phase 2 safety and immunogenicity study of a live Francisella tularensis vaccine completed.

• EMA withdrawal · 2017-06-02
  EMA Application withdrawn: Solithromycin Triskel EU Services (solithromycin) — Triskel EU Services Ltd

  The EMA reports withdrawal of the Solithromycin application by Triskel EU Services Ltd for uses including tularemia, pneumonia, and anthrax.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2016-01-13
  Clinical Trial Update: Phase II Tularemia Vaccine Comparison [Phase 2]

  A Phase II trial comparing tularemia vaccines conducted by NIAID has completed.